case_images: PMC11144851_01
case_images: Positron emission tomography/computed tomography (PET/CT) images acquired before surgery on 17 March 2022.
case_images: fphar-15-1364871-g001.jpg
case_images: PMC11144851_01_fphar-15-1364871-g001.jpg
case_images: F1
case_images: Additionally, abnormal glucose metabolism was observed in a nodule in their left upper lung, first lumbar vertebrae, and left adnexa (Figure 1).
case_images: Representative abdominal and chest-enhanced CT images acquired at different times during treatment. (A) Baseline CT images acquired on 12 May 2022. (B) CT image assessment performed on 6 December 2022. (C) CT image assessment performed on 12 April 2023. (D) CT images acquired on 19 September 2023. The red arrows indicate lung lesions, and black arrows indicate lumbar soft tissue.
case_images: fphar-15-1364871-g002.jpg
case_images: PMC11144851_01_fphar-15-1364871-g002.jpg
case_images: F2
case_images: Furthermore, bone disruption was noted in the 12th thoracic spine, first lumbar vertebra, and left adnexa (Figure 2A). Each time, the efficacy of the treatment was assessed consistently as a PR (Figures 2B, C). After treatment, the lung metastasis decreased in size and the bone destruction of the affected vertebrae had also diminished (Figure 2D).